ArticleCancer immunology, immunotherapy : CII2021

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.

Jiyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.